Skip to search formSkip to main contentSkip to account menu

RenaGel

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Objective: To investigate the effects of phosphonoformic acid (PFA) and sevelamer hydrochloride (Renagel) on renal type IIa… 
2010
2010
  • 2010
  • Corpus ID: 46973312
Recommended Sep 2008; Revised Jul 2009, May 2010, Aug 2010, Aug 2011, Dec 2014 This draft guidance, once finalized, will… 
2002
2002
BACKGROUND Haemodialysis patients frequently have simultaneous hypercalcemia and hyperphosphatemia, posing a therapeutic dilemma… 
2002
2002
Renal osteodystrophy (ROD) encompasses several distinct skeletal complications resulting from the metabolic abnormalities… 
2001
2001
The effects of sevelamer hydrochloride (Renagel®; hereafter referred to as sevelamer), a noncalcemic phosphate binder, on renal… 
Review
1999
Review
1999
Renagel is a novel, nonabsorbed, phosphate binding polymer free of aluminum and calcium. In hemodialysis patients, Renagel… 
Review
1999
Review
1999
  • K. von Appen
  • 1999
  • Corpus ID: 26583803
RenaGel, developed by GelTex, is a polymer that binds and removes dietary phosphate from the intestinal tract without being…